Trial Profile
Drug Use Investigation For RESCRIPTOR (Regulatory Post Marketing Commitment Plan).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Delavirdine (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Sponsors Pfizer
- 22 Sep 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 22 Aug 2009 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 23 Jul 2009 Planned end date changed from 1 Jun 2009 to 1 Jul 2009 as reported by ClinicalTrials.gov.